Background: Cancer-associated fibroblasts (CAFs) are found in primary and advanced tumours. They are primarily involved in tumour progression through complex mechanisms with other types of cells in the tumour microenvironment. However, essential fibroblasts-related genes (FRG) in bladder cancer still need to be explored, and there is a shortage of an ideal predictive model or molecular subtype for the progression and immune therapeutic assessment for bladder cancer, especially muscular-invasive bladder cancer based on the FRG. Materials and methods: CAF-related genes of bladder cancer were identified by analysing single-cell RNA sequence datasets, and bulk transcriptome datasets and gene signatures were used to characterize them. Then, 10 types of machine learning algorithms were utilised to determine the hallmark FRG and construct the FRG index (FRGI) and subtypes. Further molecular subtypes combined with CD8+ T-cells were established to predict the prognosis and immune therapy response. Results: Fifty-four BLCA-related FRG were screened by large-scale scRNA-sequence datasets. The machine learning algorithm established a 3-genes FRGI. High FRGI represented a worse outcome. Then, FRGI combined clinical variables to construct a nomogram, which shows high predictive performance for the prognosis of bladder cancer. Furthermore, the BLCA datasets were separated into two subtypes – fibroblast hot and cold types. In five independent BLCA cohorts, the fibroblast hot type showed worse outcomes than the cold type. Multiple cancer-related hallmark pathways are distinctively enriched in these two types. In addition, high FRGI or fibroblast hot type shows a worse immune therapeutic response. Then, four subtypes called CD8-FRG subtypes were established under the combination of FRG signature and activity of CD8+ T-cells, which turned out to be effective in predicting the prognosis and immune therapeutic response of bladder cancer in multiple independent datasets. Pathway enrichment analysis, multiple gene signatures, and epigenetic alteration characterize the CD8-FRG subtypes and provide a potential combination strategy method against bladder cancer. Conclusions: In summary, the authors established a novel FRGI and CD8-FRG subtype by large-scale datasets and organised analyses, which could accurately predict clinical outcomes and immune therapeutic response of BLCA after surgery.
Acute kidney injury (AKI) remains a major clinical challenge and is largely driven by excessive oxidative stress, inflammatory responses, and tubular cell apoptosis. However, effective therapeutic strategies that simultaneously target these pathological processes are still lacking. We developed a pH-responsive ultrasmall Fe-kaempferol (Fe-Kae) nanoplatform with coordinated antioxidant and anti-inflammatory activities for AKI treatment. Owing to their ultrasmall size and pH-responsive properties, Fe-Kae nanoparticles preferentially accumulated in injured renal tissues and exhibited robust renoprotective effects in multiple murine AKI models, including ischemia-reperfusion injury, cisplatin-induced nephrotoxicity, and calcium oxalate-induced kidney injury. Integrated transcriptomic and metabolomic analyses of ischemia-reperfusion-injured kidneys revealed that Fe-Kae treatment markedly enhanced efferocytosis-associated pathways and induced coordinated metabolic reprogramming, characterized by optimized tricarboxylic acid cycle activity and enhanced glutathione metabolism. This study establishes a nanomedicine-based therapeutic strategy that couples efferocytosis enhancement with metabolic reprogramming to achieve effective renoprotection. Our findings highlight pH-responsive ultrasmall metal-polyphenol nanoplatforms as a promising paradigm for the treatment of AKI.
24 November 2025 in Ecotoxicology and Environmental Safety
With the rapid expansion of industrial and commercial applications, graphene-based 2D nanomaterials such as graphene oxide (GO) are increasingly released into the environment, raising concerns about their environmental accumulation and the likelihood of human exposure. While previous studies have primarily focused on the cytotoxic effects of pristine GO (P-GO) at high exposure doses, the biological effects of GO under real environmental conditions remain poorly understood. Notably, atmospheric environmental media, such as ozone, can significantly alter the physicochemical properties of GO, thereby modulating its biological effects. In this study, we employed a non-direct toxicity dose to demonstrate that ozone aging can significantly modify the physicochemical properties of GO and enhance its low-dose exposure-mediated pro-tumor progression effect. Mechanistically, ozone-aged GO (O-GO) treatment increases the membrane localization of integrin αV, leading to the activation of the PI3K/AKT/mTOR signaling pathway, which drives bladder tumor proliferation. Furthermore, O-GO enhances the TGF-β signaling pathway by upregulating the expression levels of the TGF-β receptor, promoting bladder tumor cell invasiveness and metastasis. These findings provide novel insights into the tumor-promoting effects of GO at non-direct toxicity dose and emphasize the necessity of considering environmental aging process when assessing its environmental health and safety (EHS) risks. Given the expanding use of graphene-based materials in daily human life, our study highlights the urgent need for greener development strategies to mitigate potential health risks associated with GO exposure.